Shire op record hunt according analysts

Tomorrow the English company Shire will publish her past quarter's results. Based on the analysts' estimates both the revenue and the net result would be the highest in years. Over the current book year the total revenue will be 15,05 billion GBp (consensus estimates). The expected revenue would be the highest in her history. This is hugely more than 2016's revenue of 11,4 billion GBp.

Historical revenues and results Shire plus estimates 2017

financial analysis

The analysts anticipate for 2017 a record net profit a 4,54 billion GBp. According to most of the analysts the company will have a profit per share for this book year of 498 GBp. Based on this the price/earnings-ratio is 8,55.

For this year the analysts expect a dividend of 38 GBp per share. Shire 's dividend yield thus equals 0,89 percent. The average dividend yield of the pharmaceutical companies equals a low 1,33 percent.

Recent target prices around 5800 GBp

The most recent recommendations for the pharmaceutical company are from HSBC , Deutsche Bank and Jefferies & Co..

Shire 's market capitalization is based on the number of outstanding shares around 2558,58 billion GBp.

At 10.18 the stock trades 0,69 percent lower at 4256,5 GBp.

Historical stock prices Shire past 10 years

financial analysis shire

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.